Han C - Search Results

1

High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.

Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brünner N, Harris AL. Johansen JS, et al. Among authors: han c. Breast Cancer Res Treat. 2003 Jul;80(1):15-21. doi: 10.1023/A:1024431000710. Breast Cancer Res Treat. 2003. PMID: 12889595

2

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR.

Gal S, Fidler C, Lo YM, Taylor M, Han C, Moore J, Harris AL, Wainscoat JS. Gal S, et al. Among authors: han c. Br J Cancer. 2004 Mar 22;90(6):1211-5. doi: 10.1038/sj.bjc.6601609. Br J Cancer. 2004. PMID: 15026803 Free PMC article.

3

Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma.

Watson PH, Chia SK, Wykoff CC, Han C, Leek RD, Sly WS, Gatter KC, Ratcliffe P, Harris AL. Watson PH, et al. Among authors: han c. Br J Cancer. 2003 Apr 7;88(7):1065-70. doi: 10.1038/sj.bjc.6600796. Br J Cancer. 2003. PMID: 12671706 Free PMC article.

4

The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers.

Chakrabarti J, Turley H, Campo L, Han C, Harris AL, Gatter KC, Fox SB. Chakrabarti J, et al. Among authors: han c. Br J Cancer. 2004 Aug 31;91(5):954-8. doi: 10.1038/sj.bjc.6602059. Br J Cancer. 2004. PMID: 15328513 Free PMC article.

5

The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.

Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL, Fox SB. Gunningham SP, et al. Among authors: han c. Clin Cancer Res. 2000 Nov;6(11):4278-86. Clin Cancer Res. 2000. PMID: 11106244

6

Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.

Currie MJ, Gunningham SP, Han C, Scott PA, Robinson BA, Harris AL, Fox SB. Currie MJ, et al. Among authors: han c. Clin Cancer Res. 2001 Apr;7(4):918-27. Clin Cancer Res. 2001. PMID: 11309342

7

Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents.

Han C, Braybrooke JP, Deplanque G, Taylor M, Mackintosh D, Kaur K, Samouri K, Ganesan TS, Harris AL, Talbot DC. Han C, et al. Br J Cancer. 2003 Oct 6;89(7):1166-71. doi: 10.1038/sj.bjc.6601218. Br J Cancer. 2003. PMID: 14520440 Free PMC article.

8

A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.

Braybrooke JP, O'Byrne KJ, Propper DJ, Blann A, Saunders M, Dobbs N, Han C, Woodhull J, Mitchell K, Crew J, Smith K, Stephens R, Ganesan TS, Talbot DC, Harris AL. Braybrooke JP, et al. Among authors: han c. Clin Cancer Res. 2000 Dec;6(12):4697-704. Clin Cancer Res. 2000. PMID: 11156222 Clinical Trial.

9

Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.

Gunningham SP, Currie MJ, Han C, Turner K, Scott PA, Robinson BA, Harris AL, Fox SB. Gunningham SP, et al. Among authors: han c. Cancer Res. 2001 Apr 1;61(7):3206-11. Cancer Res. 2001. PMID: 11306510

10

Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.

Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL. Chia SK, et al. Among authors: han c. J Clin Oncol. 2001 Aug 15;19(16):3660-8. doi: 10.1200/JCO.2001.19.16.3660. J Clin Oncol. 2001. PMID: 11504747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,016 results

Search Page

Filters